Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: It is time to'go live with ASU 2018-12, otherwise known as long-duration targeted improvements (LDTI). For companies that have single premium limited payment contracts, additional work will be necessary under LDTI if the contracts are currently utilizing a break-even discount rate to defer the excess of the gross premium over the net premium, i.e. the deferred profit liability. This is mainly driven by requirements under LDTI to update for actual experience and review assumptions at least on an annual basis. This session is designed to cover LDTI implications specific to carriers of single premium limited payment contracts, including changes to how deferred profit liabilities are calculated going forward under LDTI and their impact to financial statements. By attending the session, you will: - Identify the LDTI implementation issues impacting their immediate annuity business. - Determine how balances will be established at transition. - Describe the explicit DPL calculations required going forward under LDTI, and their impact to financial statements.

Description: Insurance carriers are continually challenging to innovate and evolve emerging underwriting toolswisely. A growing number of new tools continue to emerge. Uncover insights and gaina technical understanding on two models from validation studies recently conducted. Find out more information on ways to evaluate models for bias an fairness. Perspectives will be shared from both a direct carrier and reinsurance standpoint. By attending the session, you will: Gain more insight into emerging underwriting tools and methods to evaluate them.

Description: Explore LDTI impact to life pricing profit metrics and discuss considerations in life product development to be ready for LDTI. By attending the session, you will: Be able to better understand LDTI impacts to life product pricing and be prepared for the LDTI implementation.

Description: As an increasing number of insurance companies, both traditional and startup, attempt to attract new customers, we see waves of product innovation ideas with goals to break into the under and un-insured markets. Some of these ideasare intended to be served as alternatives to traditional insurance focusing on adding enhancements to existing products ranging from flexible benefit design to accelerated underwriting. Others look to engage and attract new customers through a streamlined sales process in order to cultivate customer relationships and increase brand recognition. Explore how innovative companies break through obstacles from both the actuarial and compliance standpoint to bring new solutions to the marketplace. By attending the session, you will: - Understand types of innovation taking place in the life insurance industry. - Provide ideas for product of the future. - Learn different aspects of innovation on life insurance such as distribution, cost and compliance.

Description: Join us as some of the hottest topics are debated by a multi-discipline panel of industry experts focusing on potential impacts to key performance metrics. Will their arguments sway you? The final say is yours as audience polling decides which side wins the day. This fiery clash will include such topics as: what's really driving mortality?, can I really assume 'all else equal' when making underwriting changes?,I dare you to step over this line - is there an inflection point in fluidless underwriting as qualification rates increase with continued upward pressure?,how many years to credible mortality?, can I really tell if this is working anytime soon? and how effective are leading performance indicators? By attending the

Description: As accelerated underwriting continues to evolve, it is a delicate balance to ensure these programs are managed effectively for both short- and long-term results. And there's debate about whether these programs are getting too aggressive. Join panelists as they share their viewpoints on the state of accelerated underwriting, the data sources, models, tools and techniques commonly used, how the landscape is destined to change with more dynamic approaches in underwriting, and how best to monitor these programs, and the impacts of these programs to carriers and the industry as a whole.

Description: After listening to experts address various topics that affect our work as appointed actuaries, take the time to discuss these issues with yourpeers. The Smaller Insurance Company/Chief Actuary Forum presents a unique format for focusing on issues faced by actuaries in leadership positions or actuaries supporting the Chief Actuary. By discussing critical issues with your peers, you will leave with ideas to incorporate in your business environment. The Forum will feature presentations to introduce three of the discussion topics, followed by an opportunity to break into smaller discussion groups and rotate among topics. By attending the session, you will: Be able to better determine how torespond to some of the challenges you face and establish relationships with other actuaries experiencing similar issues.

Description: The qualification of life insurance under Sections 7702 and 7702A can often be complex and result in inadvertent instance of noncompliance for life insurance companies. This session with explore the complexities of product tax compliance from a due diligence perspective as well as discuss other alternatives companies may have as they administer reductions in benefit under Section 7702A.